Influenza is a respiratory viral infection that typically occurs during winter months. Most significant disease is caused by influenza virus A and B, which can cause epidemic or pandemic outbreaks. The importance of influenza as a cause of serious illness and asthma attacks is increasingly appreciated. Despite uncertainties about effectiveness, influenza vaccines and antiviral drugs are usually reccommended for people with asthma.
The Task Force will address uncertainties over the management of influenza in people with asthma. To this end, we will perform a structured review of the current literature regarding the burden imposed by influenza, the immunogenicity, efficacy, effectiveness, and safety of influenza vaccines, and the possible benefits of antiviral drugs in people with asthma. We will also review current influenza vaccine recommendations and vaccination coverage in the same population across the world. This review will enable the Task Force to identify knowledge gaps and future research needs in relation to influenza in people with asthma.
Last updated 21 January 2016